Ritlecitinib in CTCL

Clinical trial NCT05879458 · TERMINATED

Trial details

NCT number: NCT05879458
Sponsor: Icahn School of Medicine at Mount Sinai
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

CTCL Mycosis Fungoides Sezary Syndrome

Start date: 2023-05-17
Primary completion: 2025-06-25
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.